A big team effort of @GenCancerCentre @PeterMacCC @LindaMileshkin SUPER study collaborators and patients. See our recently published Nature Comms paper rdcu.be/emNWw employing clinical whole genome sequencing for diagnostically challenging #cancer of unknown primary
1
2
99
Great satisfaction to finally publish this seven years in the making @A5_Adrenal SDHB study involving multi-omic analysis of #pheo #para to understand the molecular basis of metastatic progression and treatment resistance. @PheoPara url.au.m.mimecastprotect.com…
Exciting new job opportunity for a talented research assistant to join our team at @UMCCR @UMCCR_RADIO_Lab developing novel cancer diagnostics using cell free DNA. Apply now! jobs.unimelb.edu.au/en/job/9…
Today is #NETCancerDay @netcancerday raising awareness for #NeuroendocrineCancer patients around the world. Big shout out to NET and #pheo patient advocacy groups @NECancerAus @PheoPara @CureNETs. Thanks for supporting our research @UMCCR_RADIO_Lab
Big collaborative effort from our national SUPER CUP program @PeterMacCC @LindaMileshkin and @UMCCR @UMCCR_RADIO_Lab to show how DNA and RNA tests can help resolve a #cancerofunknownprimary diagnosis. doi.org/10.1002/path.6022
Massive team effort to publish our single cell (nuclei) RNA-seq study on #pheochromocytoma and #paraganglioma nature.com/articles/s41467-0…. Thanks to all who contributed! @UMCCR @KollingINST @PeterMacRes @10xGenomics @NECancerAus @PheoPara
If you are a motivated early career bioinformatics post-doc wanting to explore whole genome sequencing of cfDNA and are interested in translational cancer research this might be the right project for you!
JOB OPPORTUNITY: #WholeGenome sequencing of cfDNA in cancer patient blood samples—the project's ultimate aim is to develop a rapid and accessible diagnostic tool for cancers of unknown primary. @UMCCR_RADIO_Lab @rtothill
jobs.unimelb.edu.au/caw/en/j…
RichTothill retweeted
JOB OPPORTUNITY: Want to join a team improving outcomes for people with cancer of unknown primary? The @UMCCR_RADIO_Lab Clinical Genomics Project Coordinator is a key role to ensure the successful delivery of this life-changing study. #genomics @rtothill
jobs.unimelb.edu.au/caw/en/j…
RichTothill retweeted
Just published! Our Pursuit article as a companion to our SUPER-NEXT CUP study launch this week. Thanks to all who made this a great success @kymm_sheehan @LindaMileshkin @UMCCR @PeterMacCC @DrClareFedele Unmasking cancers with hidden identity pursuit.unimelb.edu.au/artic…
Huge thanks to co-first authors Nick Gherardin, Kelly Waldeck and Alex Caneborg and many others who generously collaborated on this study. γδ T cells in Merkel cell carcinomas have a proinflammatory profile prognostic of patient survival cancerimmunolres.aacrjournal…
RichTothill retweeted
New #JITC article: Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma @Shahneen3 ow.ly/BBqu50BUs1P
RichTothill retweeted
Excited to have the opportunity to receive MRFF funding to study a new type of PET scan to help improve diagnosis and treatment for patients with Cancer of Unknown Primary (CUP) together with fantastic team incl @UMCCR @rtothill @BowtellLab
Congrats to Peter Mac's Professor @LindaMileshkin and team who received a Medical Research Future Fund Grant announced by @GregHuntMP today for their research into #cancer of the unknown primary. Read more: petermac.org/news/new-resear…
So proud to be working with such talented people on this project and to be receiving this important research funding for #unknownprimary
The SUPER-NEXT study to genetically sequence patients w/ cancers of unmet need—providing clearer diagnosis & targeted, personalised treatment options—has received almost $5m MRFF funding, led by @rtothill in collab w/ @LindaMileshkin @PeterMacCC >> mdhs.unimelb.edu.au/centre-f…
Nice news article in today’s Age with commentary from our Aussie scientists describing why COVID-19 became so virulent in humans..theage.com.au/national/the-p…
2
RichTothill retweeted
Principle of the Abbot #COVID-19 test. “the method is able to amplify RNA without a separate reverse transcription step.“ tandfonline.com/doi/full/10.…
RichTothill retweeted
We are in the dark on how the #COVID2019 spreads. Cannot stress more on how critical it is to test, test, test!!! We are working with @Elinav_Lab @EranElinav @WeizmannScience to develop a new technology for MASSIVE testing of #COVID2019. More info here:
instagram.com/tv/B-MUpRhgGmd…
Awesome day today hearing about the fantastic cancer research happening in western Sydney at the Crown Princess Mary Cancer Centre Symposium. From proteomics to VR medical training and of course a bit of immunology too! Thanks for the invite!
RichTothill retweeted
💥new online from my lab💥
@holmescroft+RohanBD+@DrElyseDunn discuss the mechanism of Alternative Lengthening of Telomeres, the newly discovered role for FANCM in this process, and how FANCM could be targeted in ALT cancers
#openaccess link:
xfe88.app.goo.gl/ALTcontrol
RichTothill retweeted
Ethan is #livingwithcancer as best he
can. He wants other children with #MEN2B
to be diagnosed earlier than he was.
Show your support by voting for Ethan’s film to raise awareness of
#MEN2B in the #CharityFilmAwards. @AmendInfo charityfilmawards.com/videos…



















